Opportunity Information: Apply for W81XWH 09 NFRP NIA
Apply for W81XWH 09 NFRP NIA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DOD Neurofibromatosis New Investigator Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Feb 2, 2009 and posted on Feb 2, 2009.
- Applicants must submit their applications by Apr 14, 2009. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,200,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DOD Neurofibromatosis New Investigator Award (NIA) is a Department of the Army, U.S. Army Medical Research Acquisition Activity (USAMRAA) funding opportunity under the Neurofibromatosis Research Program (NFRP) designed to help promising independent investigators establish themselves or continue their transition into a stable, productive research career focused on neurofibromatosis (NF). First introduced in fiscal year 1999, the mechanism has historically been competitive: across the years cited in the announcement, 266 applications were received and 36 were recommended for funding. The overall goal is to grow the pipeline of investigators working on NF and to encourage strong, impactful projects that respond to pressing needs in the NF community.
A key feature of this award is that prior experience in NF research is allowed but not required, which makes it especially relevant to early-stage investigators coming from adjacent fields (for example, cancer biology, neuroscience, genetics, vascular biology, imaging, pain research, or endocrinology) who can bring new ideas and tools into NF. At the same time, the program recognizes that newcomers may need disease-specific guidance, so applicants with limited NF background are strongly encouraged to include a collaborator who has established expertise in NF. Another central requirement is that proposals must include preliminary data that is relevant to NF and to the proposed project, and that data may come from the principal investigator, the research team, or a collaborator. In practical terms, the award is not meant for purely speculative concepts; it expects some evidence of feasibility or rationale that directly connects to NF.
For FY09, the announcement highlights several encouraged research areas aligned with critical unmet needs. One priority is complications of NF associated with high mortality, including neoplasms (tumors) and cerebrovascular abnormalities. Another is complications associated with high morbidity, such as skeletal problems, learning deficits, hormone-associated effects, and pain, reflecting a focus on issues that substantially affect day-to-day function and long-term quality of life. The program also encourages refinement and standardization work that can strengthen future clinical trials, such as improving imaging techniques and establishing molecular and cellular markers, along with quality-of-life metrics that can be used consistently across studies and sites. Finally, the award emphasizes translational research, including development or preclinical testing of therapeutic agents intended to treat NF, supporting the step between basic discovery and eventual clinical application.
This opportunity supports research and development activities (Science and Technology and other R&D) and offers funding through either a cooperative agreement or a grant. The opportunity does not require cost sharing or matching. The estimated total funding listed is $1,200,000, with an expectation of making 2 awards, indicating a relatively small number of funded projects and, therefore, a selective review environment. Eligibility is described as unrestricted (open to any entity type), subject to any clarifications contained in the full announcement, so applicants typically need to verify specific eligibility rules in the program announcement section referenced (including the PI eligibility requirements noted as being in Section I.C.).
A major boundary condition is that clinical trials are not permitted under this mechanism. Applicants who want to run a clinical trial are directed to a separate Clinical Trial Award mechanism within the program. This distinction signals that the New Investigator Award is intended for foundational, mechanistic, tool-building, or preclinical therapeutic work that can position projects for later-stage clinical testing rather than executing clinical trials themselves.
Administratively, the funding opportunity number is W81XWH 09 NFRP NIA, and it is associated with CFDA 12.420 (Military Medical Research and Development). The opportunity was posted on February 2, 2009, with an original and current closing date of April 14, 2009, and an archive date of May 14, 2009. For applicants needing assistance accessing the full announcement or navigating submission systems, the notice provides program announcement help and eReceipt/CDMRP helpdesk contact points, reflecting that the program is administered through the CDMRP infrastructure.
Frequently Asked Questions (FAQs)
What is the DOD Neurofibromatosis New Investigator Award (NIA)?
The DOD Neurofibromatosis New Investigator Award (NIA) is a funding opportunity under the Neurofibromatosis Research Program (NFRP) administered by the Department of the Army through the U.S. Army Medical Research Acquisition Activity (USAMRAA). It is designed to help promising independent investigators establish themselves or continue transitioning into a stable, productive research career focused on neurofibromatosis (NF).
What is the overall goal of the NIA mechanism?
The overall goal is to grow the pipeline of investigators working on NF and to encourage strong, impactful projects that respond to pressing needs in the NF community.
Is prior experience in neurofibromatosis (NF) research required?
No. Prior experience in NF research is allowed but not required, which makes this mechanism relevant to early-stage investigators coming from adjacent fields who can bring new ideas and tools into NF research.
If I am new to NF research, should I include an NF expert collaborator?
Applicants with limited NF background are strongly encouraged to include a collaborator who has established expertise in NF to provide disease-specific guidance.
Is preliminary data required for this award?
Yes. Proposals must include preliminary data that is relevant to NF and to the proposed project. The intent is to support projects with evidence of feasibility or rationale that directly connects to NF, rather than purely speculative concepts.
Whose preliminary data can be used in the application?
The preliminary data may come from the principal investigator (PI), the research team, or a collaborator, as long as it is relevant to NF and to the proposed project.
What research areas are encouraged in the FY09 announcement?
The FY09 announcement encourages research aligned with critical unmet needs in NF, including: complications associated with high mortality (such as neoplasms/tumors and cerebrovascular abnormalities); complications associated with high morbidity (such as skeletal problems, learning deficits, hormone-associated effects, and pain); refinement and standardization efforts that strengthen future clinical trials (including improved imaging techniques, molecular and cellular markers, and quality-of-life metrics); and translational research such as development or preclinical testing of therapeutic agents intended to treat NF.
Does the award support translational research and therapeutic development?
Yes. The opportunity emphasizes translational research, including development or preclinical testing of therapeutic agents intended to treat NF, supporting work that bridges basic discovery and eventual clinical application.
Are clinical trials allowed under this mechanism?
No. Clinical trials are not permitted under the New Investigator Award mechanism. Applicants seeking to run a clinical trial are directed to a separate Clinical Trial Award mechanism within the program.
What types of activities does this opportunity support?
This opportunity supports research and development activities (Science and Technology and other R&D), consistent with foundational, mechanistic, tool-building, or preclinical therapeutic work related to NF.
What funding instruments are used for awards under this opportunity?
Funding is offered through either a cooperative agreement or a grant.
Is cost sharing or matching required?
No. The opportunity does not require cost sharing or matching.
How much total funding is estimated, and how many awards are expected?
The estimated total funding is $1,200,000, with an expectation of making 2 awards. This indicates a selective review environment with a relatively small number of funded projects.
How competitive has this mechanism been historically?
The announcement notes that historically the mechanism has been competitive. Across the years cited, 266 applications were received and 36 were recommended for funding.
Who is eligible to apply?
Eligibility is described as unrestricted (open to any entity type), subject to clarifications in the full announcement. Applicants are instructed to verify specific eligibility rules in the program announcement section referenced, including PI eligibility requirements noted as being in Section I.C.
What is the funding opportunity number for this announcement?
The funding opportunity number is W81XWH 09 NFRP NIA.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 12.420 (Military Medical Research and Development).
When was this opportunity posted and when did it close?
The opportunity was posted on February 2, 2009. The original and current closing date is April 14, 2009. The archive date is May 14, 2009.
Where can applicants get help with the announcement or submission systems?
The notice references program announcement help and eReceipt/CDMRP helpdesk contact points for assistance accessing the full announcement or navigating submission systems, reflecting that the program is administered through the CDMRP infrastructure.
Why does the announcement encourage work on imaging, biomarkers, and quality-of-life metrics?
The announcement encourages refinement and standardization efforts (such as imaging improvements, molecular/cellular markers, and quality-of-life metrics) to strengthen future clinical trials by enabling consistent measures across studies and sites.
Can investigators from adjacent fields apply to bring new approaches into NF?
Yes. The award is positioned to be relevant to early-stage investigators from adjacent fields (for example, cancer biology, neuroscience, genetics, vascular biology, imaging, pain research, or endocrinology) who can bring new ideas and tools into NF.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: Addressing Emerging Infectious Diseases in Bangladesh (U01)
Previous opportunity: Specialty Crop Research Initiative
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 09 NFRP NIA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 09 NFRP NIA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DOD Tuberous Sclerosis Complex Exploration Hypothesis Development Award Apply for W81XWH 09 TSCRP EHDA Funding Number: W81XWH 09 TSCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DOD Tuberous Sclerosis Complex Career Transition Award Apply for W81XWH 09 TSCRP CARTA Funding Number: W81XWH 09 TSCRP CARTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 1 High Energy Lasers Fiber Development and Improvement Apply for BAA 09 11 PKM CALL1 Funding Number: BAA 09 11 PKM CALL1 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 2 Optical Isolation Apply for BAA 09 11 PKM CALL2 Funding Number: BAA 09 11 PKM CALL2 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 3 Mid Infrared Laser Source and Laser Development Apply for BAA 09 11 PKM CALL3 Funding Number: BAA 09 11 PKM CALL3 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 4 High Power Microwave Windows First Category Window Apply for BAA 09 11 PKM CALL4 Funding Number: BAA 09 11 PKM CALL4 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Directed Energy Materials Program CALL 5 High Power Microwave Windows Second Category Window Apply for BAA 09 11 PKM CALL5 Funding Number: BAA 09 11 PKM CALL5 Agency: Air Force Research Lab Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| GLANSER Geospatial Location Accountability Navigation System for Emergency Responders Apply for BAA09 02 Funding Number: BAA09 02 Agency: Office of Procurement Operations Grants Division Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Funding Opportunity Notice for FY 2009 SBIR/STTR Phase II Grant Applications Apply for DE PS02 09ER09 09 Funding Number: DE PS02 09ER09 09 Agency: Chicago Service Center Category: Science and Technology and other Research and Development Funding Amount: $750,000 |
| 2009 NGA University Research Initiatives (NURI) BAA Apply for HM1582 09 BAA A103 Funding Number: HM1582 09 BAA A103 Agency: National Geospatial Intelligence Agency Category: Science and Technology and other Research and Development Funding Amount: $6,750,000 |
| ROSES 2008 Astronomy and Physics Research and Analysis Apply for NNH08ZDA001N APRA Funding Number: NNH08ZDA001N APRA Agency: NASA Headquarters Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer New Investigator Award Apply for W81XWH 09 PCRP NIA Funding Number: W81XWH 09 PCRP NIA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Training Award Apply for W81XWH 09 PCRP PCTA Funding Number: W81XWH 09 PCRP PCTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Physician Research Training Award Apply for W81XWH 09 PCRP PRTA Funding Number: W81XWH 09 PCRP PRTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Genetic Studies of Food Allergies Research Program Investigator Initiated Research Award Apply for W81XWH 09 GSFARP IIRA Funding Number: W81XWH 09 GSFARP IIRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Population based Idea Development Award Apply for W81XWH 09 PCRP PBIDA Funding Number: W81XWH 09 PCRP PBIDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer HBCU Student Summer Training Program Award Apply for W81XWH 09 PCRP STPA Funding Number: W81XWH 09 PCRP STPA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DTRA FY2009 2011 Basic Research for Combating Weapons of Mass Destruction (WMD) Broad Agency Announcement (BAA) Apply for HDTRA1 08 10 BRCWMD BAA Funding Number: HDTRA1 08 10 BRCWMD BAA Agency: Defense Threat Reduction Agency Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY09 DOD Prostate Cancer Health Disparity Training Award Apply for W81XWH 09 PCRP HDTA Funding Number: W81XWH 09 PCRP HDTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Microsystems Technology Office Wide Broad Agency Announcement Apply for DARPA BAA 09 25 Funding Number: DARPA BAA 09 25 Agency: DARPA MTO BAA 09 25 Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 09 NFRP NIA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
